| Financial Year |
March 31 2023 |
| Monetary Funds |
59,985,422.93 |
| Held-for-trading Financial Assets |
600,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
536,127,054.40 |
| Advances to Suppliers |
9,434,552.66 |
| Other Receivables |
2,335,834.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
26,079.45 |
| Dividend Receivable |
-- |
| Inventories |
380,811,591.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
59,738,800.48 |
| Total Current Assets |
1,049,033,256.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
345,499,150.59 |
| Under-construction Projects |
162,048,124.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
3,297,177.02 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
108,039,065.95 |
| R&D expenses |
-- |
| Goodwill |
460,530.39 |
| Long-Term Deferred and Prepaid Expenses |
7,016,802.44 |
| Deferred Income Tax Assets |
380,887.44 |
| Other Non-Current Assets |
23,312,139.34 |
| Sub-Total of Non-Current Assets |
711,767,498.61 |
| Total Assets |
1,760,800,755.01 |
| Short-Term Loans |
334,749,797.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
38,747,810.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,983,329.77 |
| Taxes Payable |
1,483,511.24 |
| Interest Payable |
276,053.50 |
| Dividend Payable |
-- |
| Other payables |
3,335,402.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
92,623.61 |
| Sub-Total of Current Liabilities |
382,585,007.24 |
| Long-term Loans |
-- |
| Bonds Payable |
216,086,563.33 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,428,405.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
222,428,128.56 |
| Total Liabilities |
605,013,135.80 |
| Paid-In Capital(Or Share Stock) |
438,730,556.00 |
| Capital Surplus |
161,438,078.46 |
| Surplus Reserve |
32,479,191.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
481,681,414.12 |
| Minority Stockholder's Interest |
5,059,190.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,150,728,428.95 |
| Owner's Equity（Stockholder's Equity） |
1,155,787,619.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,760,800,755.01 |
